Sharff Katie A, Song Wen-Xin, Luo Xiaoji, Tang Ni, Luo Jinyong, Chen Jin, Bi Yang, He Bai-Cheng, Huang Jiayi, Li Xinmin, Jiang Wei, Zhu Gao-Hui, Su Yuxi, He Yun, Shen Jikun, Wang Yi, Chen Liang, Zuo Guo-Wei, Liu Bo, Pan Xiaochuan, Reid Russell R, Luu Hue H, Haydon Rex C, He Tong-Chuan
Molecular Oncology Laboratory, Department of Surgery, The University of Chicago Medical Center, Chicago, Illinois 60637, the Key Laboratory of Diagnostic Medicine designated by Chinese Ministry of Education and The Affiliated Hospitals of Chongqing Medical University, Chongqing 400016, China, the Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California 90095, and the Department of Radiology, The University of Chicago Medical Center, Chicago, Illinois 60637.
Molecular Oncology Laboratory, Department of Surgery, The University of Chicago Medical Center, Chicago, Illinois 60637, the Key Laboratory of Diagnostic Medicine designated by Chinese Ministry of Education and The Affiliated Hospitals of Chongqing Medical University, Chongqing 400016, China, the Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California 90095, and the Department of Radiology, The University of Chicago Medical Center, Chicago, Illinois 60637; Molecular Oncology Laboratory, Department of Surgery, The University of Chicago Medical Center, Chicago, Illinois 60637, the Key Laboratory of Diagnostic Medicine designated by Chinese Ministry of Education and The Affiliated Hospitals of Chongqing Medical University, Chongqing 400016, China, the Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California 90095, and the Department of Radiology, The University of Chicago Medical Center, Chicago, Illinois 60637.
J Biol Chem. 2009 Jan 2;284(1):649-659. doi: 10.1074/jbc.M806389200. Epub 2008 Nov 5.
Pluripotent mesenchymal stem cells (MSCs) are bone marrow stromal progenitor cells that can differentiate into osteogenic, chondrogenic, adipogenic, and myogenic lineages. We previously demonstrated that bone morphogenetic protein (BMP) 9 is one of the most potent and yet least characterized BMPs that are able to induce osteogenic differentiation of MSCs both in vitro and in vivo. Here, we conducted gene expression-profiling analysis and identified that Hey1 of the hairy/Enhancer of split-related repressor protein basic helix-loop-helix family was among the most significantly up-regulated early targets in BMP9-stimulated MSCs. We demonstrated that Hey1 expression was up-regulated at the immediate early stage of BMP9-induced osteogenic differentiation. Chromatin immunoprecipitation analysis indicated that Hey1 may be a direct target of the BMP9-induced Smad signaling pathway. Silencing Hey1 expression diminished BMP9-induced osteogenic differentiation both in vitro and in vivo and led to chondrogenic differentiation. Likewise, constitutive Hey1 expression augmented BMP9-mediated bone matrix mineralization. Hey1 and Runx2 were shown to act synergistically in BMP9-induced osteogenic differentiation, and Runx2 expression significantly decreased in the absence of Hey1, suggesting that Runx2 may function downstream of Hey1. Accordingly, the defective osteogenic differentiation caused by Hey1 knockdown was rescued by exogenous Runx2 expression. Thus, our findings suggest that Hey1, through its interplay with Runx2, may play an important role in regulating BMP9-induced osteoblast lineage differentiation of MSCs.
多能间充质干细胞(MSCs)是骨髓基质祖细胞,能够分化为成骨、软骨、脂肪和肌源性谱系。我们之前证明,骨形态发生蛋白(BMP)9是最有效但特征最少的BMP之一,能够在体外和体内诱导MSCs的成骨分化。在此,我们进行了基因表达谱分析,并确定了毛状/分裂增强子相关阻遏蛋白碱性螺旋-环-螺旋家族的Hey1是BMP9刺激的MSCs中上调最显著的早期靶标之一。我们证明,在BMP9诱导的成骨分化的即刻早期阶段,Hey1表达上调。染色质免疫沉淀分析表明,Hey1可能是BMP9诱导的Smad信号通路的直接靶标。沉默Hey1表达在体外和体内均减弱了BMP9诱导的成骨分化,并导致软骨分化。同样,组成型Hey1表达增强了BMP9介导的骨基质矿化。Hey1和Runx2在BMP9诱导的成骨分化中协同作用,并且在没有Hey1的情况下Runx2表达显著降低,这表明Runx2可能在Hey1下游发挥作用。因此,外源Runx2表达挽救了由Hey1敲低引起的有缺陷的成骨分化。因此,我们的研究结果表明,Hey1通过与Runx2相互作用,可能在调节BMP9诱导的MSCs成骨细胞谱系分化中起重要作用。